Derek Dirocco

Derek DiRocco is a Partner at RA Capital Management, L.P., and serves as a Director at multiple companies, including Bambusa Therapeutics, Rivus Pharmaceuticals, and Evommune. They held the role of Director at iTeos Therapeutics SA and Frontier Medicines until 2023, and have been involved in various board observer positions throughout their career, including with Interius BioTherapeutics and Vaxcyte. Derek completed a PhD in Pharmacology at the University of Washington and was a Post-doctoral Research Fellow at Harvard Medical School, focusing on signaling pathways in organ fibrosis and kidney cell repair.